Background/Purpose: The eosinophilic granulomatosis with polyangiitis (EGPA) guidelines recommend considering maintenance therapy after remission to reduce the risk of relapse and toxicity, but data on maintenance therapy is limited. The primary objective of this randomized, double-blind trial was to compare rituximab (RTX) and azathioprine (AZA) maintenance therapy on the duration of remission in EPGA patients … Continue reading Maintenance of remission with rituximab versus azathioprine in newly diagnosed or relapsing eosinophilic granulomatosis with polyangiitis. A prospective, randomized, controlled, double-blind trial